Point-Of-Sale Rebates In Part D: Study Highlights Trade-Offs For Medicare

Analysis funded by Pharmaceutical Care Management Association concludes that using drug rebates to lower beneficiary cost sharing at the point-of-sale would raise premiums and increase government spending.